Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Return to the main site
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Return to the main site
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> FDA: Novartis Unit Recalling Introvale Birth Control Pills
FDAnews Drug Daily Bulletin
June 8, 2012
| Vol. 9 No. 113
FDA: Novartis Unit Recalling Introvale Birth Control Pills
The U.S. Food and Drug Administration said that a Novartis AG unit is recalling a three-month birth-control regimen sold in the U.S. because of a packing error.
Fox Business
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Pharma Blog Watch
New Report Examines Efforts to Reduce the Impact of Generic Competition for Lipitor
Royal Endorsement for UAE’s Newest Drugmaker
Pathway Genomics to Offer BRCA Test